Upgrade to SI Premium - Free Trial

Summit Therapeutics (SMMT) Reports Q3 Loss of GBP0.03

November 7, 2023 7:14 AM

Summit Therapeutics (NASDAQ: SMMT) reported Q3 EPS of (GBP0.03).

For earnings history and earnings-related data on Summit Therapeutics (SMMT) click here.

Categories

Earnings